This webinar in collaboration with Avammune focuses on pursuing novel drug discovery targets with sparse or fragmented data – covering:
- What actually works when pursuing novel targets with limited data
- Why conventional generative AI fell short in new chemical space
- How to evaluate conventional AI and computational approaches
- Using Cresset for de novo design without large datasets
- Advancing from concept to trial-stage candidate (canine oncology)
- Building modality-agnostic strategies with computational chemistry
This event was hosted by our partners 20/15 Visioneers.